Navigation Links
InfoLogix to Report First Quarter Results on April 30, 2008 - Conference Call Information
Date:4/30/2008

HATBORO, Pa., April 30 /PRNewswire-FirstCall/ -- InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, will host a conference call with the financial community at 4:30 p.m. (EST) today to discuss the Company's First Quarter 2008 financial results and provide an update on business developments.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH165LOGO )

Interested parties may participate in the conference call by dialing (888) 680-0879 or (617) 213-4856 for international callers. When prompted, ask for the "First Quarter InfoLogix Earnings Conference Call" and enter passcode 71378019.

A telephonic replay of the conference call may be accessed approximately two hours after the call through May 7, 2008, by dialing (888) 286-8010 or (617) 801-6888 for international callers and entering the replay access code 28250282. You may pre-register for this call by clicking https://www.theconferencingservice.com/prereg/key.process?key=PD9U646FR

Pre-registration provides quick access to the call by bypassing the operator upon connection. You will be given a personalized pin number to enter when you dial in to the call with no hold times.

The conference call will be webcast simultaneously; it can be reached by clicking the following link: http://phx.corporate-ir.net/playerlink.zhtml?c=198199&s=wm&e=1835059 or on the InfoLogix website at

SOURCE InfoLogix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. InfoLogix Announces Approval for NASDAQ Listing
2. InfoLogix Acquires Healthcare Informatics Associates Inc. (HIA); Adds Premier Healthcare Consulting Firm and Systems Integrator
3. InfoLogix Signs Largest International Deal to Date with Healthcare Solutions Agreement in United Arab Emirates
4. InfoLogix to Report Third Quarter and Nine Month Financial Results on November 8, 2007
5. InfoLogix Featured in FOX Business News Interview on Reducing Healthcare Medication Errors - Video Available Online
6. InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL
7. Dollar Thrifty Automotive Group Expands Mobile Managed Services Contract with InfoLogix
8. InfoLogix to Report First Quarter Results on April 30, 2008
9. InfoLogix Announces First Quarter 2008 Financial Results
10. Virginia Tech Report Has National Importance
11. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... discovered that the loss of a key segment of DNA ... study to show that this kind of genetic alteration can ... . , The study, led by Dr Sadaf Farooqi from ... Wellcome Trust Sanger Institute, looked at 300 children with severe ... for types of mutation known as copy number variants (CNVs). ...
(Date:12/6/2009)... of feline DNA in virus , , SUNDAY, Dec. 6 (HealthDay ... might be found in a tiger that lived thousands or ... appears the virus took on a bit of a tiger,s ... remains in the virus to this day. That tiger, in ... of the virus that ultimately led to its infection of ...
(Date:12/6/2009)... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... 003-A1 study, known as the 003 trial, demonstrating ... and refractory multiple myeloma patients. These data were ... the 51st annual meeting of the American Society ... this trial is complete (n=269), and full results, ...
(Date:12/6/2009)... Blood clotting, or coagulation, is an ... blood vessel is injured. Sometimes, however, clots form ... injury or do not dissolve naturally, a potentially ... the 51st Annual Meeting of the American Society ... the anticoagulants aspirin and heparin with the hope ...
(Date:12/6/2009)... Treatment site www.sleeping-with-a-sleeping-disorder.com is asking people ... natural sleep aids from around the world to ... cause. The submissions will be compiled in an ... YOU, to be sold from the website in ... of the proceeds ,from sales of the E-book ...
Breaking Medicine News(10 mins):Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:AIDS May Date Back to Ancient Tiger 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2
... protein that lets mice eat more but weigh less could ... scientists from drug giant SmithKline Beecham and the University of ... Uncoupling Protein 3 (UCP3) that increases their metabolism.In what is ... than normal mice but still weigh less. , , ,"Extra ...
... the gene associated with the inherited form of primary pulmonary ... and James A. Knowles of the Columbia Genome Center is ... part by the National Heart, Lung, and Blood Institute at ... issue of the American Journal of Human Genetics, provides new ...
... concern over the AIDS crisis ravaging sub-Saharan Africa dominates much ... Conference, researchers and AIDS workers are sounding the alarm for ... have a very serious catastrophe in the offing, and if ... China, and it's not any of the other superpowers--the big ...
... low levels that are making news. Recent reports are ... and violent behavior. A new study shows that men with ... likely to report symptoms of severe depression. Edward Suarez, ... Said, "I think that at some point, measurement of ...
... they are told to consider a hysterectomy because they ... very rare that a fibroid tumor could become cancerous,' ... the Stanford University School of Medicine.,Fibroids are benign growths ... bleeding. ,According to Dr. Kevin Reynolds, chief of gynecologic ...
... to all of you who thought that one only uses ... have come out in the recent years which are dermatocentric ... which was devised for liver transplantation, there has been found ... disease because of its chronicity as well as the symptomatology ...
Other Medicine News:
(Date:12/4/2009)... FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: ... medication delivery company, today announced the launch of its ... intravenous (I.V.) medications and solutions, and now offers a ... the award-winning, environmentally responsible VisIV product. The launch of ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), ... and chemical threats, announced today that the Company ... effectiveness of Valortim® in an inhalation anthrax model ... The data are being presented during an oral ...
(Date:12/4/2009)... Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation ... and successful testing of a novel integrated light source ... optical engine design raises the bar on imaging speed ... source OCT light sources. This approach to optical ...
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Biopolymers Symposium 2009 Offers Two for One Deal 3A Attend Retailers Scorecard Seminar and Attend the EcoLabeling Summit Free 56040 1Biopolymers Symposium 2009 Offers Two for One Deal 3A Attend Retailers Scorecard Seminar and Attend the EcoLabeling Summit Free 56040 2Tim Gunn Hosts Addressing Psoriasis 28TM 29 Fashion Show to Raise Awareness of Psoriasis 56038 1Tim Gunn Hosts Addressing Psoriasis 28TM 29 Fashion Show to Raise Awareness of Psoriasis 56038 2Tim Gunn Hosts Addressing Psoriasis 28TM 29 Fashion Show to Raise Awareness of Psoriasis 56038 3Tim Gunn Hosts Addressing Psoriasis 28TM 29 Fashion Show to Raise Awareness of Psoriasis 56038 4Tim Gunn Hosts Addressing Psoriasis 28TM 29 Fashion Show to Raise Awareness of Psoriasis 56038 5Bayer Acquires Two Prescription Dermatology Product Lines From SkinMedica in the U S 13803 1Bayer Acquires Two Prescription Dermatology Product Lines From SkinMedica in the U S 13803 2Bayer Acquires Two Prescription Dermatology Product Lines From SkinMedica in the U S 13803 3
... a complete line of flowmeters, available ... 2 . They are all available ... best suit your application. With color ... the gas in use, the Amvex ...
... line of flowmeters, available in oxygen, ... They are all available in a ... your application. With color coded labels ... in use, the Amvex Flowmeter is ...
... offers a complete line of flowmeters, ... CO 2 . They are all ... to best suit your application. With ... to the gas in use, the ...
... a complete line of flowmeters, available in oxygen, air, ... in a variety of calibrations to best suit your ... the gas in use, the Amvex Flowmeter is a ... U with I. For Power Take-Off add PT to ...
Medicine Products: